The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584

Cancer Research
David Z QianRoberto Pili

Abstract

Chromatin remodeling agents such as histone deacetylase inhibitors have been shown to modulate gene expression in tumor cells and inhibit tumor growth and angiogenesis. Vascular endothelial growth factor (VEGF) and VEGF receptors represent critical molecular targets for antiangiogenesis therapy. In this study, we investigated the biological effect of the histone deacetylase inhibitor NVP-LAQ824 in combination with the VEGF receptor tyrosine kinase inhibitor PTK787/ZK222584 on tumor growth and angiogenesis. We report that treatment with NVP-LAQ824 affected tumor and endothelial cells and was associated with increased histone acetylation, p21 up-regulation, and growth inhibition. In addition, NVP-LAQ824 treatment inhibited the expression of angiogenesis-related genes such as angiopoietin-2, Tie-2, and survivin in endothelial cells and down-regulated hypoxia-inducible factor 1-alpha and VEGF expression in tumor cells. Combination treatment with NVP-LAQ824 and PTK787/ZK222584 was more effective than single agents in inhibiting in vitro and in vivo VEGF-induced angiogenesis. Endothelial cell proliferation, tube formation, and invasion into the Matrigel plugs were reduced. In mouse models with established subcutaneous prostate (PC3) ...Continue Reading

References

Jan 1, 1999·Nature·C LengauerB Vogelstein
Jan 27, 2000·Cell·D Hanahan, R A Weinberg
Mar 16, 2000·The EMBO Journal·T Kouzarides
Mar 31, 2000·Nature Medicine·G ThurstonG D Yancopoulos
Aug 3, 2000·Journal of the National Cancer Institute·P A MarksR A Rifkind
Sep 23, 2000·Nature·G D YancopoulosJ Holash
Feb 24, 2001·Cancer Metastasis Reviews·G L Semenza
Aug 4, 2001·Molecular and Cellular Biology·Y L YaoE Seto
Sep 26, 2001·Neoplasia : an International Journal for Oncology Research·M GohM Ljungman
Oct 19, 2001·Medicinal Research Reviews·P TraxlerJ Zimmermann
Mar 21, 2002·Nature Reviews. Cancer·Adrian L Harris
Mar 28, 2002·Proceedings of the National Academy of Sciences of the United States of America·Jennifer TranRobert S Kerbel
Apr 3, 2002·Trends in Molecular Medicine·Len Neckers
Jun 4, 2002·Nature Reviews. Genetics·Peter A Jones, Stephen B Baylin
Jun 20, 2002·Journal of the National Cancer Institute·Lynn HlatkyJudah Folkman
Jul 18, 2002·Nature Reviews. Drug Discovery·Ricky W Johnstone
Oct 3, 2002·Nature Reviews. Cancer·Robert Kerbel, Judah Folkman
Oct 3, 2002·Nature Reviews. Cancer·Napoleone Ferrara
Dec 14, 2002·Biochemical and Biophysical Research Communications·You Mie LeeKyu-Won Kim
Jan 2, 2003·Nature Reviews. Cancer·Dario C Altieri
Jun 13, 2003·Seminars in Oncology·Anne L ThomasWilliam P Steward
Jan 30, 2004·Cancer Cell·Mikhail V Blagosklonny

❮ Previous
Next ❯

Citations

Jan 27, 2007·Cancer Chemotherapy and Pharmacology·Henk M W VerheulRoberto Pili
Jun 30, 2012·Cancer Chemotherapy and Pharmacology·John H StricklerHerbert I Hurwitz
Dec 7, 2007·Clinical & Experimental Metastasis·Denis Mottet, Vincent Castronovo
Dec 17, 2010·Investigational New Drugs·Michael DickinsonH Miles Prince
Feb 13, 2013·Targeted Oncology·Filip JankuRazelle Kurzrock
Aug 28, 2009·Expert Reviews in Molecular Medicine·Evon PoonMargaret Ashcroft
Sep 16, 2011·The Journal of Biological Chemistry·Hao GengDavid Z Qian
Apr 28, 2007·The Cancer Journal·Janice M Mehnert, Wm Kevin Kelly
Feb 28, 2008·The Cancer Journal·Li Shen, Roberto Pili
Jun 3, 2009·Journal of Hematology & Oncology·Shundong CangDelong Liu
Nov 6, 2009·Drug News & Perspectives·M B Lustberg, B Ramaswamy
May 14, 2009·Therapeutics and Clinical Risk Management·Zoheir Ezziane
Mar 13, 2014·Journal of Molecular Cell Biology·Annalisa ZecchinMauro Giacca
Jun 2, 2005·Proceedings of the National Academy of Sciences of the United States of America·Nina JendreykoCarlos F Barbas
Nov 20, 2014·Future Medicinal Chemistry·Chao DingYuyang Jiang
Jan 19, 2010·Cellular and Molecular Life Sciences : CMLS·Pierre CloseAlain Chariot
Oct 14, 2005·Current Oncology Reports·Aparna A Kamat, Anil K Sood
Jun 1, 2005·Expert Opinion on Therapeutic Patents·Jacques Dumas, Julie A Dixon
Aug 9, 2005·Expert Opinion on Therapeutic Targets·Roberto R Rosato, Steven Grant
Mar 22, 2006·Expert Opinion on Therapeutic Targets·Gregg L Semenza
Apr 13, 2007·Expert Review of Anticancer Therapy·Douglas Marchion, Pamela Münster
Dec 4, 2009·Expert Review of Anticancer Therapy·Ila Tamaskar, Roberto Pili
Nov 1, 2009·Expert Review of Clinical Pharmacology·Deborah L Marrocco-TallarigoLisa M Butler
Jun 18, 2010·Expert Review of Anticancer Therapy·Brahma N SinghShi-Wen Jiang
Feb 17, 2007·Expert Opinion on Investigational Drugs·Edwina N ScottAnne L Thomas
Jan 4, 2008·Expert Opinion on Drug Safety·Jeff M BerryJoseph A Hill
Jul 27, 2006·Expert Opinion on Drug Metabolism & Toxicology·Eun Joo ChungJane B Trepel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.